Mannkind Corp (NASDAQ:MNKD)

Data as of Jan 30
 +0.07 / +1.11%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

MannKind Corp. is a biopharmaceutical company. It focuses on the discovery, development and commercialization of therapeutic products for diseases, such as diabetes and cancer. The company's product AFREZZA inhalation powder, which is an ultra rapid-acting insulin that is in late-stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia. MannKind was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Valencia, CA.

Contact Information

MannKind Corp.
28903 North Avenue Paine
Valencia California 91355
P:(661) 775-5300
Investor Relations:
(661) 295-4784



Individual stakeholders37.86%
Mutual fund holders12.97%
Other institutional10.42%

Top Executives

Hakan S. EdstromPresident, Chief Executive Officer & Director
Juergen A. MartensChief Operating Officer & Chief Technology Officer
Matthew J. PfefferCFO, Vice President & Head-Investor Relations
David B. ThomsonSecretary, Vice President & General Counsel
Robert A. BaughmanSenior Vice President-Clinical Sciences

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.